Lassen Therapeutics Raises $31 Million to Pursue IL-11 Antibody for Cancer and Fibrosis June 18, 2020
Lassen Therapeutics Launches to Discover and Develop Novel Antibody Therapeutics Including Lead Program Targeting IL-11 to Treat Fibrosis and Oncology June 17, 2020
PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19 June 17, 2020
